Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer

Published in: Turkish journal of medical sciences (2021)

Folfirinox is an option for the first-line treatment of patients with pancreatic cancer and good performance status.

Keyphrases